NF-κB – a target in the inflammation of bone destruction

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.1, 2005-02, pp. : 191-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF-κB as a Therapeutic Target for Cardiovascular Disease

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 303-311

Karger

Access to resources Recommend Favorite

NF-&kgr;B as a Target for Modulating Inflammatory Responses

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5735-5745

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation and Cancer: When NF-&kgr;B Amalgamates the Perilous Partnership

Current Cancer Drug Targets, Vol. 5, Iss. 5, 2005-08 ,pp. : 325-344

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of NF-&kgr;B Signaling on Apoptosis in Chronic Inflammation-Associated Carcinogenesis

Current Cancer Drug Targets, Vol. 10, Iss. 6, 2010-09 ,pp. : 593-599

Bentham Science Publishers

Access to resources Recommend Favorite

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite